PathAI

Happy Thanksgiving from PathAI! We are thankful for you, our team and our partners ?? #happythanksgiving

Register and attend our upcoming #webinar next week: AI-Powered Pathology for #MASH & #LiverDisease Research and #DrugDevelopment ?? Date: Friday, December 6th ?? Time: 11AM - 12PM ET ?? Panelists: Eric Walk MD, FCAP, Christina Jayson, Ph.D., Lara P. Murray, PhD, Ylaine Gerardin, Adam Stanford-Moore ?? Register: https://lnkd.in/eqxusN_j Join us for an insightful session exploring the groundbreaking role of AI-powered pathology in advancing MASH and liver disease research through drug development! This free webinar offers a unique look at our Liver Explore? tool, designed to provide high-resolution insights into tissue biology and fibrosis microarchitecture. ???????? ??????'???? ??????????: - Histological insights that can be uniquely captured by AI-powered pathology - An inside look at building AI tools specifically for liver disease research - Live demonstration of Liver Explore?? - Case studies and guidance on leveraging AI-powered insights in MASH and liver disease - An overview of Liver Explore?’s versatility in MASH and non-MASH liver disease applications Register now to learn how our tools are transforming liver disease insights and drug development! #Pathology #AI #MASH #LiverDisease #DrugDevelopment ?????????? ??????????????? ???? ?????? ???????????????? ?????? ????????. ?????? ?????? ?????? ???? ???????????????????? ????????????????????.

Drug Discovery & Development's Brian K. Buntz recently interviewed?PathAI’s VP of Product and Translational Research, Ben Glass?, about the development and impact of PathExplore Fibrosis?, our AI-based tool that analyzes fibrosis and collagen structures from H&E-stained whole-slide tissue images for #oncology research. ? ?? Learn more about how the technology moved from an internal research project to a revolutionary #AIPathology tool: https://lnkd.in/ect7DrrW ? #Cancer #CancerResearch #BiomarkerDiscovery #AI #Pathology ??????????????????????? ???????????????? ???? ?????? ???????????????? ?????? ????????. ?????? ?????? ?????? ???? ???????????????????? ????????????????????.

We’re thrilled to share that ???????????? has been recognized for the “?????????????????????? ???????????????????? ???? ?????? ????????” by the ?????????????? ???????????????????????? ????????????! ?? Our ??????????????? ???????????????? earned this prestigious award for its transformative impact on pathology workflows, integrating cutting-edge AI to power digital #pathology adoption. A huge thank you to our team, partners, and the pathology community for making this achievement possible. Together, we’re redefining what’s possible for #digitalpathology! ?? Learn more about AISight? and how it’s shaping the future of pathology: https://lnkd.in/eEJrGCMC #AIPathology #PathAI #BioTechBreakthrough #AISight #DigitalPathology

?? We’re thrilled to announce PathAI is a Deloitte Technology Fast 500? Winner! This recognition highlights our rapid growth and innovation in transforming pathology with AI-powered tools. From enabling #digitalpathology workflows through AISight? to supporting #drugdevelopment with cutting-edge #biopharma solutions, we’re redefining the field. ?? Read the #PressRelease: https://lnkd.in/ehtz5hyC Thank you to our team, partners, and the community driving this exciting journey forward! ?? #TechFast500 #AI #Pathology #Innovation #Deloitte #TechnologyFast500 #Fast500 #CancerResearch #AIPathology ??????????????? ???? ?????? ???????????????? ?????? ???????? ???? ?????? ????; ?????????????? ???? ???? ????-?????? ???? ???????????? ?????? ???????? ???? ????

???? Bonjour! We are live at CARREFOUR #PATHOLOGIE 2024 at the iconic CNIT Forest in Paris La Défense!?Stop by booth 21 to see #AIPathology in action and live demos of AISight?. Meet with Max Zinner, Suzana Vega Harring MD MBA, and Vincent Billaut to discover how AISight Dx IMS is revolutionizing pathology workflows and enhancing case management to drive efficiency and precision in pathology lab processes. Learn more about AISight?:?https://lnkd.in/ef5NWxse ??????????????? ???? ?????? ???????????????? ?????? ???????? ???? ?????? ????; ?????????????? ???? ???? ????-?????? ???? ???????????? ?????? ???????? ???? ???? ???? Bonjour à tous ! Nous sommes en direct de CARREFOUR PATHOLOGIE 2024, au CNIT Forest à Paris La Défense ! Passez au stand 21 pour découvrir l’#IAenPathologie en action avec des démonstrations en direct d’AISight?.Rencontrez Max Zinner, Suzana Vega Harring MD MBA, Vincent Billaut et découvrez comment notre système de gestion d’images ??AISight Dx???révolutionne les flux de travail en pathologie et améliore la gestion des cas pour optimiser l’efficacité et la précision des processus en laboratoire de pathologie. En savoir plus sur AISight? :?https://lnkd.in/epFBqjwy ?????????????? ???? ?????? ??????????????é ????-?????? ???? ???????????? ???? ???????? ???? ??????????????-??????, ?????????????? ?????? ??é????????é à ???? ?????????????????? ?????? é????????-????????. #Pathology #AI #AIPathology #biotech #Pathologie #CAREFOURPATHOLOGIE #CAREFOURPATHOLOGIE2024 #anatomicpathology #biotech #biotechnology

?? Upcoming #Webinar: AI-Powered Pathology for #MASH & Liver Disease Research and Drug Development ?? Friday, December 6th ?? 11AM - 12PM ET ?? Panelists: Eric Walk MD, FCAP, Christina Jayson, Ph.D., Lara P. Murray, PhD, Ylaine Gerardin, Adam Stanford-Moore Join us for an insightful session exploring the groundbreaking role of AI-powered pathology in advancing MASH and liver disease research through drug development! This free webinar offers a unique look at our Liver Explore? tool, designed to provide high-resolution insights into tissue biology and #fibrosis microarchitecture. ???????? ??????’???? ??????????: - Histological insights that can be uniquely captured by AI-powered pathology - An inside look at building AI tools specifically for liver disease research - Live demonstration of Liver Explore?? - Case studies and guidance on leveraging AI-powered insights in MASH and liver disease - An overview of Liver Explore?’s versatility in MASH and non-MASH liver disease applications Register now to learn how our tools are transforming liver disease insights and drug development! #Pathology #AI #MASH #LiverDisease #DrugDevelopment #Liver #LiverResearch #healthtech #AIPathology #DigitalPathology ????????????????????????? ???? ?????? ???????????????? ?????? ????????. ?????? ?????? ?????? ???? ???????????????????? ????????????????????.

We're excited to announce partnerships and integrations with several leading #AI digital pathology companies - Deep Bio Inc., DoMore Diagnostics, Paige, and Visiopharm - through our AISight? Image Management System! ?? Read the #PressRelease: https://lnkd.in/eTqX-tKw These partnerships will enable seamless access for pathologists to top-tier AI algorithms, boosting #pathology workflow efficiency, #biomarker quantification, risk stratification, and more. PathAI is committed to offering the most versatile, reliable, and interoperable IMS on the market. This is a major step forward in bringing cutting-edge technologies to the fingertips of #pathologists, to enhance #diagnostics and improve patient outcomes. Learn more or contact us at [email protected]. #DigitalPathology #Innovation #Partnerships #AISight #biotech #biotechnology #AIinHealthcare #healthtech -AISight? is for Research Use Only in the US; AISight Dx is CE-IVD in Europe and UKCA in UK

Today is the last day of AASLD's The Liver Meeting! Thank you to those who have visited PathAI’s booth and met with our amazing team about using #AIPathology for #MASH and #LiverDisease research and #drugdevelopment.? Feel free to stop by our booth in the next few hours to see live demos of Liver Explore? AIM-MASH+ and AIM-MASH AI-Assist from our scientific team and round out another incredible year.? Here’s to American Association for the Study of Liver Diseases (AASLD)’s #TLM24!??? ?????????? ???????????????, ??????-????????+, ?????? ??????-???????? ????-???????????? ?????? ?????? ???????????????? ?????? ????????. ?????? ?????? ?????? ???? ???????????????????? ????????????????????.?

We are thankful to the?Hoag Health System?for inviting our Global Head of Commercial, Digital Diagnostics,?Parth Chodavadia, MD?to showcase PathAI’s AISight? #ImageManagementSystem at the recent Hoag Board of Directors retreat! We are energized by our partnership with Hoag as well as the potential for #digitalpathology and #AI in health systems. #IMS #AISight #ArtificialIntelligence #AIPathology #pathology ?????????????? ???? ?????? ???????????????? ?????? ????????. ?????? ?????? ?????? ???? ???????????????????? ????????????????????. Pictured ??: David R. Braxton M.D. (Chief of Molecular Pathology, Hoag Hospital), Anisha Gururaj (Senior Manager, Sales and Partnerships - Digital Diagnostics, PathAI), and Parth Chodavadia, MD (Global Head of Commercial - Digital Diagnostics, PathAI)